JAMDA
Volume 11, Issue 3 , Pages 211-221 , March 2010

Thrombotic Risk and Immobility in Residents of Long-Term Care Facilities

  • Barbara J. Zarowitz, PharmD, BCPS, FCCP, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • Corresponding Author InformationAddress correspondence to Barbara J. Zarowitz, PharmD, BCPS, FCCP, CGP, FASCP, Omnicare, Inc., 33510 Schoolcraft Road, Livonia, MI 48150.
    • ,
  • Eric Tangalos, MD

      Affiliations

    • Mayo Clinic, Rochester, MN
    • ,
  • Allen Lefkovitz, PharmD, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • ,
  • Henry Bussey, PharmD, FCCP

      Affiliations

    • College of Pharmacy, University of Texas at Austin, Austin, TX
    • ,
  • Steven Deitelzweig, MD

      Affiliations

    • Department of Hospital Medicine, Ochsner Medical Center and Tulane University Medical College, New Orleans, LA
    • ,
  • Edith Nutescu, PharmD

      Affiliations

    • School of Pharmacy, University of Illinois, Chicago, IL
    • ,
  • Terrence O'Shea, PharmD, CGP, FASCP

      Affiliations

    • Omnicare, Inc, Livonia, MI
    • ,
  • Barbara Resnick, RNP

      Affiliations

    • University of Maryland, Baltimore, MD
    • ,
  • Arthur Wheeler, MD

      Affiliations

    • Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The literature evaluation, on-site meeting, travel to the meeting, and biostatistical support were supported by an investigator-initiated grant (DCLB-547377.1) from Sanofi-Aventis Pharmaceuticals, USA.

PII: S1525-8610(09)00409-5

doi: 10.1016/j.jamda.2009.11.006

JAMDA
Volume 11, Issue 3 , Pages 211-221 , March 2010

Article Tools

* Image Usage & Resolution